FDA FDA touts SRNT conference March 2-5 in Chicago (that FDA appears to be sponsoring)

[Bill Godshall]

On February 9, the FDA CTP sent out the e-mail below (but didn't post it on FDA's website)
urging FDA e-mail recipients to attend SRNT's annual meeting next month, where many FDA officials and their funding recipients will promote agency's policy agenda (including FDA's e-cig deeming ban) and funded junk science.
Bill

The Spotlight on Science is a quarterly science and research digest from the FDA Center for tobacco Products.

Meet Our Scientists at the 2016 Society for Research on Nicotine and tobacco Annual Meeting
CTP will be participating in the 2016 annual meeting of the Society for Research on Nicotine and Tobacco on March 2—5 in Chicago.

Register for the CTP Pre-Conference Workshop

Register for the CTP pre-conference workshop, Perspectives on Nicotine: Science and Policy, on March 2 from 8 a.m. to 12 noon. This workshop includes three parts:

• Part 1: Presentations to provide brief overviews on the basic science of nicotine, including data from the Population Assessment of Tobacco and Health (PATH) study
• Part 2: A presentation to provide insights into addressing a different complex public health issue related to harm reduction
• Part 3: A panel discussion to address the range of policy perspectives on nicotine

Register Now.

Meet CTP Experts

Please join CTP as we participate in panel discussions, present our tobacco regulatory research in more than 30 oral and poster presentations, and host an exhibit booth where you can meet CTP subject matter experts.

Don’t miss these selected SRNT sessions involving CTP:

Special Symposium: How Science Informs the FDA’s Regulatory Decisions: PMTA and MRTPA

Wednesday, March 2, from 4:45 p.m. to 6:15 p.m.

CTP Director Mitch Zeller, J.D.; CTP Office of Science (OS) Director David L. Ashley, Ph.D.; CTP OS Director of the Division of Individual Health Science Ii-Lun Chen, M.D.; and CTP OS Director of Population Health Science Conrad J. Choiniere, Ph.D., will discuss how science informs regulatory decisions such as premarket tobacco applications (PMTA) and modified risk tobacco product applications (MRTPA).

Presidential Symposium: Highlighted Findings from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study

Thursday, March 3, 6 to 7 p.m.

CTP’s Nicolette Borek, Ph.D., along with PATH Study Principal Investigator Andrew Hyland, Ph.D., from the Roswell Park Cancer Institute and Kevin Conway, Ph.D., from the National Institute on Drug Abuse, will present findings from the first wave of results from the PATH study—a nationally representative, longitudinal cohort study of 45,971 adults and youth in the United States aged 12 years and older.

Symposium: What We Know About Appeal: Implications for Product Regulation

Friday, March 4, 1 to 2:30 p.m.

CTP Office of Science Deputy Director for Research Cathy L. Backinger, Ph.D., M.P.H., and Assistant Deputy Director for Research Dana M. van Bemmel, Ph.D., M.P.H., will co-chair this symposium that explores the range of science addressing the appeal of tobacco products including product design, flavors, packaging and labeling, and marketing.

Lecture: Current US Anti-Tobacco Campaigns: A Synthesis of Evidence from Formative and Outcomes Studies

Friday, March 4, 4:30 to 5:30 p.m.

CTP’s Tesfa Alexander, Ph.D., Truth Initiative’s Donna Vallone, Ph.D., M.P.H. and the Centers for Disease Control and Prevention’s Bob Rodes, M.S., M.B.A., M.Ed. will discuss the formative, monitoring, and outcome studies of the FDA’s “The Real Cost” campaign, Truth Initiative (formerly Legacy)’s truth campaign, and CDC’s Tips from Former Smokers campaign. Preliminary outcome data will provide evidence of the effectiveness of each campaign on campaign-related knowledge, attitudes, beliefs and behaviors.

 

[Sir Kadly]

• Part 1: Presentations to provide brief overviews on the basic JUNK science of nicotine

Special Symposium: How JUNK Science Informs the FDA’s Regulatory Decisions: PMTA and MRTPA

Lecture: Current US Anti-Tobacco Campaigns: A Synthesis of Misinformation from Formative and Outcomes Studies

I think they need a proofreader. I've gone ahead and fixed some of the most obvious mistakes, think they will resend it with my corrections?

 

[sofarsogood]

On February 9, the FDA CTP sent out the e-mail below (but didn't post it on FDA's website)
urging FDA e-mail recipients to attend SRNT's annual meeting next month, where many FDA officials and their funding recipients will promote agency's policy agenda (including FDA's e-cig deeming ban) and funded junk science.
Bill

The Spotlight on Science is a quarterly science and research digest from the FDA Center for Tobacco Products.

Meet Our Scientists at the 2016 Society for Research on Nicotine and Tobacco Annual Meeting
CTP will be participating in the 2016 annual meeting of the Society for Research on Nicotine and Tobacco on March 2—5 in Chicago.

Register for the CTP Pre-Conference Workshop

Register for the CTP pre-conference workshop, Perspectives on Nicotine: Science and Policy, on March 2 from 8 a.m. to 12 noon. This workshop includes three parts:

• Part 1: Presentations to provide brief overviews on the basic science of nicotine, including data from the Population Assessment of Tobacco and Health (PATH) study
• Part 2: A presentation to provide insights into addressing a different complex public health issue related to harm reduction
• Part 3: A panel discussion to address the range of policy perspectives on nicotine

Register Now.

Meet CTP Experts

Please join CTP as we participate in panel discussions, present our tobacco regulatory research in more than 30 oral and poster presentations, and host an exhibit booth where you can meet CTP subject matter experts.

Don’t miss these selected SRNT sessions involving CTP:

Special Symposium: How Science Informs the FDA’s Regulatory Decisions: PMTA and MRTPA

Wednesday, March 2, from 4:45 p.m. to 6:15 p.m.

CTP Director Mitch Zeller, J.D.; CTP Office of Science (OS) Director David L. Ashley, Ph.D.; CTP OS Director of the Division of Individual Health Science Ii-Lun Chen, M.D.; and CTP OS Director of Population Health Science Conrad J. Choiniere, Ph.D., will discuss how science informs regulatory decisions such as premarket tobacco applications (PMTA) and modified risk tobacco product applications (MRTPA).

Presidential Symposium: Highlighted Findings from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study

Thursday, March 3, 6 to 7 p.m.

CTP’s Nicolette Borek, Ph.D., along with PATH Study Principal Investigator Andrew Hyland, Ph.D., from the Roswell Park Cancer Institute and Kevin Conway, Ph.D., from the National Institute on Drug Abuse, will present findings from the first wave of results from the PATH study—a nationally representative, longitudinal cohort study of 45,971 adults and youth in the United States aged 12 years and older.

Symposium: What We Know About Appeal: Implications for Product Regulation

Friday, March 4, 1 to 2:30 p.m.

CTP Office of Science Deputy Director for Research Cathy L. Backinger, Ph.D., M.P.H., and Assistant Deputy Director for Research Dana M. van Bemmel, Ph.D., M.P.H., will co-chair this symposium that explores the range of science addressing the appeal of tobacco products including product design, flavors, packaging and labeling, and marketing.

Lecture: Current US Anti-Tobacco Campaigns: A Synthesis of Evidence from Formative and Outcomes Studies

Friday, March 4, 4:30 to 5:30 p.m.

CTP’s Tesfa Alexander, Ph.D., Truth Initiative’s Donna Vallone, Ph.D., M.P.H. and the Centers for Disease Control and Prevention’s Bob Rodes, M.S., M.B.A., M.Ed. will discuss the formative, monitoring, and outcome studies of the FDA’s “The Real Cost” campaign, Truth Initiative (formerly Legacy)’s truth campaign, and CDC’s Tips from Former Smokers campaign. Preliminary outcome data will provide evidence of the effectiveness of each campaign on campaign-related knowledge, attitudes, beliefs and behaviors.

First, it offends me to see these people being paid to do this. Second, a 'drug abuse' expert is invited to talk about vaping? Who decides that vaping is drug abuse? Third, tobacco control people have no claim on vaping. It competes with their tobacco product they are working so hard to protect.

 

[Bill Godshall]

The huge SRNT conference abstract directory is at
http://c.ymcdn.com/sites/www.srnt.o...ting/Program/FINAL_SRNT_Abstract_WEB02171.pdf

Looks like it includes 100+ DHHS funded studies that demonize vapor products, cigars, hookah, nicotine and/or flavorings to lobby for FDA's Deeming Ban.

 

[nicnik]

The huge SRNT conference abstract directory is at
http://c.ymcdn.com/sites/www.srnt.o...ting/Program/FINAL_SRNT_Abstract_WEB02171.pdf

Looks like it includes 100+ DHHS funded studies that demonize vapor products, cigars, hookah, nicotine and/or flavorings to lobby for FDA's Deeming Ban.

I searched the page for the word "conclusions". Reading a bunch of those, and 'funding' which is usually the next paragraph, and it looks like you're right, that it's a bunch of governmant funded demonizing.

 

[Kent C]

I noticed a few names that have come up before on ANTZ stuff:

Ii-Lun Chen

FDA Summary of Adverse Events on Electronic Cigarettes

Andrew Hyland, Ph.D., from the Roswell Park Cancer Institute and colleague of the more widely known and seen - Maciej Goniewicz - basically the "ecigs are worse than cigarettes" guy.... although his comments on that has varied throughout the last few years.....

“These results suggest that some types of electronic cigarettes might expose their users to the same or even higher levels of carcinogenic formaldehyde than tobacco smoke,” Goniewicz said. “Users of high-voltage e-cigarettes need to be warned about this increased risk of harmful effects.”

Andrew Hyland is chairman of the department of health behavior at Roswell Park’s Division of Cancer Prevention & Population Sciences and serves as a senior editor for the journal Tobacco Control.

“This speaks to the fact that right now there’s no regulatory oversight of any of the manufacturing, the distribution or the marketing,” he said.

Supporter of vaping bans in public.


http://www.bizjournals.com/buffalo/...park-research-e-cigarettes-produce-toxic.html